Bright Minds Biosciences(us:DRUG)

    38.65

    -1.18%

    Updated on 2024-12-22

    Open:38.39
    Close:38.65
    High:39.10
    Low:36.81
    Pre Close:39.11
    Volume:51873.00
    Amount:2.00M
    Turnover:0.75%
    Shares:6.95M
    MarketCap:268.56M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3071975404.43%013
    2024-03-31112133754.78%315
    2023-12-3182283605.12%231
    2023-09-30111946015.16%317
    2023-06-30111147430.61%225
    2023-03-31105836343.09%231
    2022-12-31154082402.18%128
    2022-09-30164129092.35%624
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Advisorshares Investments Llc1760383.94%-12081-6.42%
    2024-03-31Citadel Advisors Llc178290.40%17829
    2024-03-31Jane Street Group, Llc137950.31%13795
    2024-03-31National Bank Of Canada /Fi/50000.11%5000
    2024-03-31Royal Bank Of Canada6120.01%334120.14%
    2024-03-31Aspire Private Capital, Llc1000.00%0
    2024-03-31Blackrock Inc.10
    2024-03-31Virtu Financial Llc0-10399
    2024-03-31Renaissance Technologies Llc0-11996
    2024-03-31Ubs Group Ag0-622

    About

    Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
    Address:19 Vestry Street

    Market Movers